Michael Carducci

12PUBLICATIONS
157CO-AUTHORS
Cancer geneticsPeripheral nervous systemRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 26, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Feb 19, 2026
Comparison of Characteristics and Outcomes of Patients With Metastatic Prostate Cancer With and Without Next-Generation Sequencing Testing.

Madelyn F Klugman, Hua-Ling Tsai, Yasaman Iranmanesh

|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching

|Jan 28, 2025
CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor.

Rajendra Kumar, Janet Mendonca, Abhishek Shetty

|Oct 07, 2024
Correction: Behavioral Weight Loss Programs for Cancer Survivors Throughout Maryland: Protocol for a Pragmatic Trial and Participant Characteristics.

Gerald J Jerome, Lawrence J Appel, Linda Bunyard

|Jul 30, 2024
High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial.

Channing J Paller, Marianna L Zahurak, Adel Mandl

Pageof 2

Frequent Collaborators

5 joint publications

Channing Paller

4 joint publications

Catherine H Marshall

3 joint publications

Mark C Markowski

3 joint publications

Samuel R Denmeade